1Gluckman E,Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from a HLA-identical sibling. N Engl J Med, 1989,321:1174-1178.
2Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med, 2000,342:1846-1854.
3Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases:influence of CD34 cell dose and HLA disparity ontreatment-related mortality and survival. Blood, 2002, 100: 1611-1618.
4Jacobsohn DA, Hewlett B, Ranalli M, et al. Outcomes of unrelated cord blood transplants and allogeneic related hematopoetic stem cell transplants in children with high-risk acute lymphocytic leukemia.BMT,2004,34(10):901-907.
5Fruchtman SM, Hurlet A,Dracker R,et al. The successful treatment of severe aplastic anemia with autologous cord blood transplantation.Biol Blood Marrow Transplant ,2004, 10(11):741-742.
6Fernandez MN. Unrelated cord blood transplantation with simultaneous infusion of cultured expanded cells from second donor. Blood,1999,94:3196-3203.
7Barker JN, Wagner JE. Umbilical cord blood transplantation: current practice and future innovations. Crit Review in Oncol/Hematol,2003,48:35-43.
